COVID-19 Long Haulers and the Implications for Pharma
Download the whitepaper
COVID-19 Long Haulers have emerged from the pandemic as a new population of COVID-19 patients that have shown post-recovery symptoms and co-morbidities that were nonexistent prior to infection.
Download the whitepaper and discover:
- Who Long Haulers are and their spectrum of indications
- What challenges long haulers pose for HCPs, healthcare systems & patients
- How a patient-centric care blueprint can support long haulers
Download the whitepaper to learn how pharma can improve patient outcomes for long haulers both during and after the pandemic.